Nifty
Sensex
:
:
11937.65
40707.31
40.85 (0.34%)
162.94 (0.40%)

Pesticides & Agrochemicals

Rating :
74/99  (View)

BSE: 533138 | NSE: ASTEC

1033.75
15.70 (1.54%)
21-Oct-2020 | 4:02PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1026.00
  •  1062.00
  •  1016.25
  •  1018.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  61157
  •  632.21
  •  1367.00
  •  310.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,023.52
  • 31.22
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,120.74
  • 0.15%
  • 7.72

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 69.96%
  • 2.78%
  • 22.44%
  • FII
  • DII
  • Others
  • 0.56%
  • 0.26%
  • 4.00%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.92
  • 16.17
  • 12.45

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 18.47
  • 21.97
  • 4.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 25.56
  • 57.07
  • 10.82

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 24.26
  • 29.65
  • 31.32

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.23
  • 6.13
  • 5.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.25
  • 18.11
  • 15.61

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
112
77
45%
181
134
35%
125
119
5%
140
113
24%
Expenses
84
71
18%
138
111
25%
104
98
6%
125
89
40%
EBITDA
28
6
343%
43
23
85%
21
21
-2%
15
23
-35%
EBIDTM
25%
8%
14%
17%
17%
18%
11%
21%
Other Income
1
1
33%
5
6
-9%
4
3
28%
2
2
-2%
Interest
2
3
-56%
2
3
-32%
3
4
-6%
4
3
22%
Depreciation
6
6
13%
6
5
12%
6
5
8%
6
4
27%
PBT
22
-2
-
40
20
96%
16
15
2%
8
18
-56%
Tax
6
-1
-
8
7
13%
3
5
-36%
3
6
-60%
PAT
16
-1
-
31
13
145%
12
10
22%
5
12
-54%
PATM
14%
-1%
7%
10%
10%
8%
4%
10%
EPS
8.26
-0.57
-
15.91
6.49
145%
6.21
5.09
22%
2.70
5.90
-54%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
558
523
431
368
299
247
267
207
175
113
109
Net Sales Growth
26%
21%
17%
23%
21%
-7%
29%
18%
55%
3%
 
Cost Of Goods Sold
4,881
339
279
235
180
161
179
133
118
78
81
Gross Profit
-4,324
184
151
133
119
86
88
74
57
35
28
GP Margin
-775%
35%
35%
36%
40%
35%
33%
36%
32%
31%
26%
Total Expenditure
450
437
354
299
236
215
213
172
148
97
94
Power & Fuel Cost
-
29
24
18
16
14
4
7
9
5
3
% Of Sales
-
6%
6%
5%
5%
6%
1%
3%
5%
5%
3%
Employee Cost
-
30
25
22
20
16
12
11
9
6
4
% Of Sales
-
6%
6%
6%
7%
6%
5%
6%
5%
5%
4%
Manufacturing Exp.
-
10
9
7
7
5
1
6
0
0
1
% Of Sales
-
2%
2%
2%
2%
2%
0%
3%
0%
0%
1%
General & Admin Exp.
-
11
8
9
8
10
9
7
5
3
2
% Of Sales
-
2%
2%
2%
3%
4%
3%
3%
3%
3%
2%
Selling & Distn. Exp.
-
6
4
5
3
4
5
5
5
2
2
% Of Sales
-
1%
1%
1%
1%
2%
2%
3%
3%
2%
2%
Miscellaneous Exp.
-
13
6
2
3
6
3
2
1
3
2
% Of Sales
-
3%
1%
1%
1%
3%
1%
1%
1%
3%
1%
EBITDA
107
85
76
69
62
32
54
35
27
15
16
EBITDA Margin
19%
16%
18%
19%
21%
13%
20%
17%
15%
14%
14%
Other Income
12
12
11
8
3
7
1
0
1
1
1
Interest
11
13
12
11
12
13
13
9
7
6
4
Depreciation
24
23
19
15
14
10
13
15
12
9
6
PBT
85
61
56
52
39
16
30
12
9
2
7
Tax
20
14
20
21
10
7
-2
2
3
1
2
Tax Rate
24%
23%
36%
37%
33%
59%
-17%
22%
32%
30%
30%
PAT
65
48
36
35
19
5
15
9
6
1
5
PAT before Minority Interest
65
48
36
35
19
5
15
9
6
1
5
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
12%
9%
8%
10%
6%
2%
6%
4%
3%
1%
4%
PAT Growth
95%
33%
2%
83%
285%
-66%
70%
46%
338%
-72%
 
EPS
33.07
24.24
18.23
17.81
9.76
2.54
7.54
4.42
3.04
0.69
2.49

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
247
202
170
138
118
135
113
106
99
97
Share Capital
20
20
20
20
19
19
19
18
17
17
Total Reserves
226
182
149
118
98
116
95
87
80
80
Non-Current Liabilities
6
9
5
2
6
49
54
53
36
46
Secured Loans
0
0
0
0
8
13
18
21
11
41
Unsecured Loans
0
0
0
0
0
0
0
0
1
2
Long Term Provisions
0
0
0
0
0
1
1
1
0
0
Current Liabilities
318
249
238
194
203
178
117
102
96
36
Trade Payables
202
63
100
57
68
88
46
46
31
23
Other Current Liabilities
17
10
14
10
25
8
10
6
5
6
Short Term Borrowings
99
176
124
126
109
77
57
47
59
0
Short Term Provisions
1
0
0
0
1
5
4
3
1
7
Total Liabilities
572
461
413
334
328
362
284
261
231
179
Net Block
194
167
115
103
95
133
132
121
76
73
Gross Block
271
221
150
124
105
201
188
161
105
92
Accumulated Depreciation
77
54
35
22
10
68
55
40
29
20
Non Current Assets
240
213
182
135
136
158
150
143
123
90
Capital Work in Progress
24
19
42
8
20
12
6
13
44
9
Non Current Investment
0
0
0
0
0
0
0
0
0
8
Long Term Loans & Adv.
22
27
25
22
18
13
11
9
3
0
Other Non Current Assets
0
0
0
3
4
0
0
0
0
0
Current Assets
332
248
232
198
191
204
135
119
108
90
Current Investments
0
0
0
0
0
0
0
0
12
0
Inventories
121
93
78
66
71
72
77
51
50
37
Sundry Debtors
161
122
123
111
81
104
51
63
32
34
Cash & Bank
1
1
2
4
6
12
4
5
4
3
Other Current Assets
48
2
1
1
33
16
2
0
10
15
Short Term Loans & Adv.
42
30
27
17
31
15
2
0
10
15
Net Current Assets
13
0
-7
5
-12
26
18
16
12
53
Total Assets
572
461
413
334
328
362
284
261
231
179

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
168
15
65
19
-13
7
15
16
9
16
PBT
61
56
56
29
12
19
9
6
1
5
Adjustment
37
30
18
35
19
23
25
20
15
10
Changes in Working Capital
88
-55
6
-38
-39
-32
-17
-8
-6
4
Cash after chg. in Working capital
187
32
80
26
-8
10
16
18
10
19
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-18
-16
-15
-7
-5
-3
-2
-2
-1
-3
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-74
-52
-49
-18
-16
-19
-19
-13
-50
-17
Net Fixed Assets
-55
-48
-60
-7
80
-15
-17
-26
-47
-36
Net Investments
0
0
0
0
1
0
0
12
-4
17
Others
-19
-4
11
-11
-96
-4
-2
1
1
2
Cash from Financing Activity
-95
37
-18
-1
31
12
3
-2
42
2
Net Cash Inflow / Outflow
0
0
-3
1
2
0
-1
1
1
1
Opening Cash & Equivalents
0
0
3
2
1
1
5
4
3
2
Closing Cash & Equivalent
0
0
0
3
2
1
4
5
4
3

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
126
103
86
70
60
70
61
58
57
57
ROA
9%
8%
9%
6%
1%
5%
3%
2%
1%
3%
ROE
21%
19%
23%
15%
4%
12%
8%
6%
1%
5%
ROCE
20%
20%
24%
16%
11%
12%
11%
9%
5%
8%
Fixed Asset Turnover
2.12
2.32
2.70
2.73
1.61
1.46
1.26
1.46
1.21
1.51
Receivable days
99
104
115
111
136
100
95
89
101
107
Inventory Days
75
73
71
80
106
96
106
95
133
113
Payable days
112
81
94
100
137
112
88
93
92
71
Cash Conversion Cycle
61
96
92
91
105
83
112
90
142
149
Total Debt/Equity
0.40
0.87
0.74
0.92
1.08
0.69
0.73
0.69
0.74
0.45
Interest Cover
6
6
6
3
2
2
2
2
1
3

News Update


  • Astec Lifesciences sells entire equity stake in Astec Europe Sprl
    1st Sep 2020, 10:50 AM

    Accordingly, Astec Europe Sprl ceases to be a subsidiary of the Company

    Read More
  • Astec Lifesciences - Quarterly Results
    22nd Jul 2020, 15:39 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.